Although the pathogenic process of IBD is unclear, an imbalance in proinflammatory and regulatory CD4+ T cell responses and damage to the epithelial barrier, which is the first-line defense of the mucosal immune system, are crucial for the development and progression of IBD [16, 32–34]. This evidence concerns the gene CD4 and inflammatory bowel disease.